Between May and June 2024, the QUSTom project achieved a significant milestone: collecting data and information for the clinical validation of its new breast cancer diagnostic technology. A total of 59 women, aged between 50 and 69, participated. They were selected as participants in the Vall d’Hebron University Hospital‘s early breast cancer detection programme in Barcelona.
Read this article about it: Project QUSTom launches clinical validation of radiation-free breast cancer diagnostic technique
Now, in the current stage, following the work of doctors and radiologists, it is computing’s turn to analyze and process the obtained data.
Financed by the European Innovation Council (EIC) of the European Union, the project aims to introduce a revolutionary new modality of medical imaging, combining 3D tomographic ultrasound and supercomputing.
To provide a detailed overview of each step of the clinical validation, we have created the following infographic. The project is currently in step 5 of the process listed below. Check it out:
About the QUSTom Project
QUSTom is pioneering a novel approach to medical imaging, utilizing 3D tomographic ultrasound combined with supercomputing. This cutting-edge technology is entirely safe for patients, as it avoids the use of radiation, providing enhanced image quality and improved tumour monitoring, among other advantages.
This innovation is particularly beneficial for women with dense breast tissue, which is challenging to diagnose using current methods and affects 40% of women worldwide.
The QUSTom consortium is coordinated by the Barcelona Supercomputing Center (BSC) and includes the Vall d’Hebron Research Institute (VHIR), FrontWave Imaging, Karlsruher Institut für Technologie (KIT), Arctur, and Imperial College London as an associate partner.
